🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the pharmacokinetics and safety of single dose and multiple dos...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-11
Trial ID
NCT01443208
Treatments Being Tested
In this Phase 4 trial we will study the safety, tolerability and efficacy o...
Status
Completed
Location
Rush University Medical Center
Start Date
2010-12
Trial ID
NCT02058693
Treatments Being Tested
DVS is the main metabolite of the antidepressant/anxiolytic medication Venl...
Status
Unknown
Location
University of Ottawa Institute of Mental Health Research
Start Date
2010-04
Trial ID
NCT01101152
Treatments Being Tested
The study evaluated the long-term safety of Desvenlafaxine Succinate (DVS) ...
Status
Completed
Location
Birmingham Research Group Inc.
Start Date
2003-08
Trial ID
NCT01309542
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of esc...
Status
Completed
Location
Medpace
Start Date
2014-02
Trial ID
NCT02055300
Desvenlafaxine succinate (DVS) is a potent and selective serotonin and nore...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00406640
Treatments Being Tested
The purpose of this study is to evaluate if DVS SR is safe and effective in...
Status
Terminated
Location
Multiple Locations
Start Date
2008-06
Trial ID
NCT00696787
Treatments Being Tested
The main purpose of this study is to assess the effect of a single suprathe...
Status
Completed
Location
Celerion
Start Date
2017-05-12
Trial ID
NCT03155893
Treatments Being Tested
The primary purpose of this study is to evaluate the long-term safety and t...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-05
Trial ID
NCT00669110
Treatments Being Tested